Genexine, Inc.
- Biotech or pharma, therapeutic R&D
Genexine(KOSDAQ 095700) is a preclinical and clinical-stage Korean biotech company with first-in-class oncology assets based on the proprietary platform technology; bioPROTAC (TPD) & hybrid Fc long-acting, & DNA cancer vaccine.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}